Selected research
Market Analysis & Forecast
Global Mice Model Genetic Engineering Market Analysis and Forecast 2026-2032
Market perspective
The global Mice Model Genetic Engineering market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Mice Model Genetic Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Mice Model Genetic Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Mice Model Genetic Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Mice Model Genetic Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Mice Model Genetic Engineering include B BIOCYTOGEN, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Ozgene Pty Ltd., Taconic Biosciences, Inc. and PolyGene AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Mice Model Genetic Engineering, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Mice Model Genetic Engineering, also provides the revenue of main regions and countries. Of the upcoming market potential for Mice Model Genetic Engineering, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Mice Model Genetic Engineering revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mice Model Genetic Engineering market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Mice Model Genetic Engineering revenue, projected growth trends, production technology, application and end-user industry.
Mice Model Genetic Engineering Segment by Company
B BIOCYTOGEN
Charles River Laboratories
Cyagen Biosciences
Gempharmatech
genOway
ingenious targeting laboratory
Ozgene Pty Ltd.
Taconic Biosciences, Inc.
PolyGene AG
THE JACKSON LABORATORY
Yale School of Medicine
University of North Carolina
University of Nebraska Medical Center
Monash University
UMass Chan Medical School
University of Bonn
Columbia University
The University of Arizona
The Weizmann Institute of Science
The Hebrew University of Jerusalem
The Technion – Israel Institute of Technology
Hadassah BrainLabs
Mice Model Genetic Engineering Segment by Type
CRISPR Knockout
CRISPR Knockin
Random Insertions
ES Cell Modification (homologous recombination)
Others
Mice Model Genetic Engineering Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic & Research Facilities
Contract Research & Manufacturing Organizations
Mice Model Genetic Engineering Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mice Model Genetic Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mice Model Genetic Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mice Model Genetic Engineering.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Mice Model Genetic Engineering in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Mice Model Genetic Engineering company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mice Model Genetic Engineering revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Mice Model Genetic Engineering Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
Table 2. CRISPR Knockout Major Player
Table 3. CRISPR Knockin Major Player
Table 4. Random Insertions Major Player
Table 5. ES Cell Modification (homologous recombination) Major Player
Table 6. Others Major Player
Table 7. Global Mice Model Genetic Engineering Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
Table 8. Pharmaceutical Companies Major Player
Table 9. Biotechnology Companies Major Player
Table 10. Academic & Research Facilities Major Player
Table 11. Contract Research & Manufacturing Organizations Major Player
Table 12. Mice Model Genetic Engineering Industry Trends
Table 13. Mice Model Genetic Engineering Industry Drivers
Table 14. Mice Model Genetic Engineering Industry Opportunities and Challenges
Table 15. Mice Model Genetic Engineering Industry Restraints
Table 16. Global Mice Model Genetic Engineering Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 17. Global Mice Model Genetic Engineering Market Size by Region (2021-2026) & (US$ Million)
Table 18. Global Mice Model Genetic Engineering Market Share by Region (2021-2026)
Table 19. Global Mice Model Genetic Engineering Market Size by Region (2027-2032) & (US$ Million)
Table 20. Global Mice Model Genetic Engineering Market Share by Region (2027-2032)
Table 21. Global Mice Model Genetic Engineering Revenue by Players (US$ Million) & (2021-2026)
Table 22. Global Mice Model Genetic Engineering Revenue Market Share by Players (2021-2026)
Table 23. Global Mice Model Genetic Engineering Key Players Ranking, 2024 VS 2025 VS 2026
Table 24. Global Mice Model Genetic Engineering Key Players Headquarters & Area Served
Table 25. Global Mice Model Genetic Engineering Players, Product Type & Application
Table 26. Global Mice Model Genetic Engineering Players Establishment Date
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Mice Model Genetic Engineering by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Global Mice Model Genetic Engineering Revenue by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 30. Global Mice Model Genetic Engineering Revenue by Type (2021-2026) & (US$ Million)
Table 31. Global Mice Model Genetic Engineering Revenue by Type (2027-2032) & (US$ Million)
Table 32. Global Mice Model Genetic Engineering Revenue Market Share by Type (2021-2026)
Table 33. Global Mice Model Genetic Engineering Revenue Market Share by Type (2027-2032)
Table 34. Global Mice Model Genetic Engineering Revenue by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 35. Global Mice Model Genetic Engineering Revenue by Application (2021-2026) & (US$ Million)
Table 36. Global Mice Model Genetic Engineering Revenue by Application (2027-2032) & (US$ Million)
Table 37. Global Mice Model Genetic Engineering Revenue Market Share by Application (2021-2026)
Table 38. Global Mice Model Genetic Engineering Revenue Market Share by Application (2027-2032)
Table 39. B BIOCYTOGEN Company Information
Table 40. B BIOCYTOGEN Business Overview
Table 41. B BIOCYTOGEN Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 42. B BIOCYTOGEN Mice Model Genetic Engineering Product Portfolio
Table 43. B BIOCYTOGEN Recent Development
Table 44. Charles River Laboratories Company Information
Table 45. Charles River Laboratories Business Overview
Table 46. Charles River Laboratories Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 47. Charles River Laboratories Mice Model Genetic Engineering Product Portfolio
Table 48. Charles River Laboratories Recent Development
Table 49. Cyagen Biosciences Company Information
Table 50. Cyagen Biosciences Business Overview
Table 51. Cyagen Biosciences Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 52. Cyagen Biosciences Mice Model Genetic Engineering Product Portfolio
Table 53. Cyagen Biosciences Recent Development
Table 54. Gempharmatech Company Information
Table 55. Gempharmatech Business Overview
Table 56. Gempharmatech Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 57. Gempharmatech Mice Model Genetic Engineering Product Portfolio
Table 58. Gempharmatech Recent Development
Table 59. genOway Company Information
Table 60. genOway Business Overview
Table 61. genOway Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 62. genOway Mice Model Genetic Engineering Product Portfolio
Table 63. genOway Recent Development
Table 64. ingenious targeting laboratory Company Information
Table 65. ingenious targeting laboratory Business Overview
Table 66. ingenious targeting laboratory Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 67. ingenious targeting laboratory Mice Model Genetic Engineering Product Portfolio
Table 68. ingenious targeting laboratory Recent Development
Table 69. Ozgene Pty Ltd. Company Information
Table 70. Ozgene Pty Ltd. Business Overview
Table 71. Ozgene Pty Ltd. Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 72. Ozgene Pty Ltd. Mice Model Genetic Engineering Product Portfolio
Table 73. Ozgene Pty Ltd. Recent Development
Table 74. Taconic Biosciences, Inc. Company Information
Table 75. Taconic Biosciences, Inc. Business Overview
Table 76. Taconic Biosciences, Inc. Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 77. Taconic Biosciences, Inc. Mice Model Genetic Engineering Product Portfolio
Table 78. Taconic Biosciences, Inc. Recent Development
Table 79. PolyGene AG Company Information
Table 80. PolyGene AG Business Overview
Table 81. PolyGene AG Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 82. PolyGene AG Mice Model Genetic Engineering Product Portfolio
Table 83. PolyGene AG Recent Development
Table 84. THE JACKSON LABORATORY Company Information
Table 85. THE JACKSON LABORATORY Business Overview
Table 86. THE JACKSON LABORATORY Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 87. THE JACKSON LABORATORY Mice Model Genetic Engineering Product Portfolio
Table 88. THE JACKSON LABORATORY Recent Development
Table 89. Yale School of Medicine Company Information
Table 90. Yale School of Medicine Business Overview
Table 91. Yale School of Medicine Mice Model Genetic Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Yale School of Medicine Mice Model Genetic Engineering Product Portfolio
Table 93. Yale School of Medicine Recent Development
Table 94. University of North Carolina Company Information
Table 95. University of North Carolina Business Overview
Table 96. University of North Carolina Mice Model Genetic Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. University of North Carolina Mice Model Genetic Engineering Product Portfolio
Table 98. University of North Carolina Recent Development
Table 99. University of Nebraska Medical Center Company Information
Table 100. University of Nebraska Medical Center Business Overview
Table 101. University of Nebraska Medical Center Mice Model Genetic Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. University of Nebraska Medical Center Mice Model Genetic Engineering Product Portfolio
Table 103. University of Nebraska Medical Center Recent Development
Table 104. Monash University Company Information
Table 105. Monash University Business Overview
Table 106. Monash University Mice Model Genetic Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Monash University Mice Model Genetic Engineering Product Portfolio
Table 108. Monash University Recent Development
Table 109. UMass Chan Medical School Company Information
Table 110. UMass Chan Medical School Business Overview
Table 111. UMass Chan Medical School Mice Model Genetic Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. UMass Chan Medical School Mice Model Genetic Engineering Product Portfolio
Table 113. UMass Chan Medical School Recent Development
Table 114. University of Bonn Company Information
Table 115. University of Bonn Business Overview
Table 116. University of Bonn Mice Model Genetic Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. University of Bonn Mice Model Genetic Engineering Product Portfolio
Table 118. University of Bonn Recent Development
Table 119. Columbia University Company Information
Table 120. Columbia University Business Overview
Table 121. Columbia University Mice Model Genetic Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Columbia University Mice Model Genetic Engineering Product Portfolio
Table 123. Columbia University Recent Development
Table 124. The University of Arizona Company Information
Table 125. The University of Arizona Business Overview
Table 126. The University of Arizona Mice Model Genetic Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. The University of Arizona Mice Model Genetic Engineering Product Portfolio
Table 128. The University of Arizona Recent Development
Table 129. The Weizmann Institute of Science Company Information
Table 130. The Weizmann Institute of Science Business Overview
Table 131. The Weizmann Institute of Science Mice Model Genetic Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. The Weizmann Institute of Science Mice Model Genetic Engineering Product Portfolio
Table 133. The Weizmann Institute of Science Recent Development
Table 134. The Hebrew University of Jerusalem Company Information
Table 135. The Hebrew University of Jerusalem Business Overview
Table 136. The Hebrew University of Jerusalem Mice Model Genetic Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. The Hebrew University of Jerusalem Mice Model Genetic Engineering Product Portfolio
Table 138. The Hebrew University of Jerusalem Recent Development
Table 139. The Technion – Israel Institute of Technology Company Information
Table 140. The Technion – Israel Institute of Technology Business Overview
Table 141. The Technion – Israel Institute of Technology Mice Model Genetic Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. The Technion – Israel Institute of Technology Mice Model Genetic Engineering Product Portfolio
Table 143. The Technion – Israel Institute of Technology Recent Development
Table 144. Hadassah BrainLabs Company Information
Table 145. Hadassah BrainLabs Business Overview
Table 146. Hadassah BrainLabs Mice Model Genetic Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Hadassah BrainLabs Mice Model Genetic Engineering Product Portfolio
Table 148. Hadassah BrainLabs Recent Development
Table 149. North America Mice Model Genetic Engineering Revenue by Type (2021-2026) & (US$ Million)
Table 150. North America Mice Model Genetic Engineering Revenue by Type (2027-2032) & (US$ Million)
Table 151. North America Mice Model Genetic Engineering Revenue by Application (2021-2026) & (US$ Million)
Table 152. North America Mice Model Genetic Engineering Revenue by Application (2027-2032) & (US$ Million)
Table 153. North America Mice Model Genetic Engineering Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 154. North America Mice Model Genetic Engineering Revenue by Country (2021-2026) & (US$ Million)
Table 155. North America Mice Model Genetic Engineering Revenue by Country (US$ Million) & (2027-2032)
Table 156. Europe Mice Model Genetic Engineering Revenue by Type (2021-2026) & (US$ Million)
Table 157. Europe Mice Model Genetic Engineering Revenue by Type (2027-2032) & (US$ Million)
Table 158. Europe Mice Model Genetic Engineering Revenue by Application (2021-2026) & (US$ Million)
Table 159. Europe Mice Model Genetic Engineering Revenue by Application (2027-2032) & (US$ Million)
Table 160. Europe Mice Model Genetic Engineering Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 161. Europe Mice Model Genetic Engineering Revenue by Country (2021-2026) & (US$ Million)
Table 162. Europe Mice Model Genetic Engineering Revenue by Country (US$ Million) & (2027-2032)
Table 163. China Mice Model Genetic Engineering Revenue by Type (2021-2026) & (US$ Million)
Table 164. China Mice Model Genetic Engineering Revenue by Type (2027-2032) & (US$ Million)
Table 165. China Mice Model Genetic Engineering Revenue by Application (2021-2026) & (US$ Million)
Table 166. China Mice Model Genetic Engineering Revenue by Application (2027-2032) & (US$ Million)
Table 167. Asia Mice Model Genetic Engineering Revenue by Type (2021-2026) & (US$ Million)
Table 168. Asia Mice Model Genetic Engineering Revenue by Type (2027-2032) & (US$ Million)
Table 169. Asia Mice Model Genetic Engineering Revenue by Application (2021-2026) & (US$ Million)
Table 170. Asia Mice Model Genetic Engineering Revenue by Application (2027-2032) & (US$ Million)
Table 171. Asia Mice Model Genetic Engineering Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million)
Table 172. Asia Mice Model Genetic Engineering Revenue by Region (US$ Million) & (2021-2026)
Table 173. Asia Mice Model Genetic Engineering Revenue by Region (US$ Million) & (2027-2032)
Table 174. SAMEA Mice Model Genetic Engineering Revenue by Type (2021-2026) & (US$ Million)
Table 175. SAMEA Mice Model Genetic Engineering Revenue by Type (2027-2032) & (US$ Million)
Table 176. SAMEA Mice Model Genetic Engineering Revenue by Application (2021-2026) & (US$ Million)
Table 177. SAMEA Mice Model Genetic Engineering Revenue by Application (2027-2032) & (US$ Million)
Table 178. SAMEA Mice Model Genetic Engineering Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 179. SAMEA Mice Model Genetic Engineering Revenue by Country (2021-2026) & (US$ Million)
Table 180. SAMEA Mice Model Genetic Engineering Revenue by Country (US$ Million) & (2027-2032)
Table 181. Research Programs/Design for This Report
Table 182. Authors List of This Report
Table 183. Secondary Sources
Table 184. Primary Sources
List of Figures
Figure 1. Mice Model Genetic Engineering Image
Figure 2. Global Mice Model Genetic Engineering Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Mice Model Genetic Engineering Market Size Share 2021 VS 2025 VS 2032
Figure 4. CRISPR Knockout Image
Figure 5. CRISPR Knockin Image
Figure 6. Random Insertions Image
Figure 7. ES Cell Modification (homologous recombination) Image
Figure 8. Others Image
Figure 9. Global Mice Model Genetic Engineering Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
Figure 10. Global Mice Model Genetic Engineering Market Size Share 2021 VS 2025 VS 2032
Figure 11. Pharmaceutical Companies Image
Figure 12. Biotechnology Companies Image
Figure 13. Academic & Research Facilities Image
Figure 14. Contract Research & Manufacturing Organizations Image
Figure 15. Global Mice Model Genetic Engineering Market Size (US$ Million) & (2021-2032)
Figure 16. Global Mice Model Genetic Engineering Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 17. Global Mice Model Genetic Engineering Market Share by Region: 2021 VS 2025 VS 2032
Figure 18. Global Mice Model Genetic Engineering Players Revenue Share Top 10 and Top 5 in 2025
Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 20. Global Mice Model Genetic Engineering Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 21. Global Mice Model Genetic Engineering Revenue Market Share 2021 VS 2025 VS 2032
Figure 22. Global Mice Model Genetic Engineering Revenue Market Share by Type (2021-2032)
Figure 23. Global Mice Model Genetic Engineering Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 24. Global Mice Model Genetic Engineering Revenue Market Share by Application (2021 VS 2025 VS 2032)
Figure 25. Global Mice Model Genetic Engineering Revenue Market Share by Application (2021-2032)
Figure 26. North America Mice Model Genetic Engineering Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 27. North America Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
Figure 28. North America Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
Figure 29. North America Mice Model Genetic Engineering Revenue Share by Country (2021-2032)
Figure 30. United States Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 31. Canada Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 32. Mexico Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 33. Europe Mice Model Genetic Engineering Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 34. Europe Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
Figure 35. Europe Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
Figure 36. Europe Mice Model Genetic Engineering Revenue Share by Country (2021-2032)
Figure 37. Germany Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 38. France Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 39. U.K. Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 40. Italy Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 41. Spain Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 42. Russia Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 43. Netherlands Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 44. Nordic Countries Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 45. China Mice Model Genetic Engineering Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 46. China Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
Figure 47. China Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
Figure 48. Asia Mice Model Genetic Engineering Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 49. Asia Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
Figure 50. Asia Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
Figure 51. Asia Mice Model Genetic Engineering Revenue Share by Region (2021-2032)
Figure 52. Japan Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 53. South Korea Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 54. India Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 55. Australia Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 56. Taiwan Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 57. Southeast Asia Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 58. SAMEA Mice Model Genetic Engineering Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 59. SAMEA Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
Figure 60. SAMEA Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
Figure 61. SAMEA Mice Model Genetic Engineering Revenue Share by Country (2021-2032)
Figure 62. Brazil Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 63. Argentina Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 64. Chile Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 65. Colombia Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 66. Peru Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 67. Saudi Arabia Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 68. Israel Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 69. UAE Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 70. Turkey Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 71. Iran Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 72. Egypt Mice Model Genetic Engineering Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 73. Years Considered
Figure 74. Research Process
Figure 75. Key Executives Interviewed
Scope & coverage.
Types
- CRISPR Knockout
- CRISPR Knockin
- Random Insertions
- ES Cell Modification (homologous recombination)
- Others
Applications
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Facilities
- Contract Research & Manufacturing Organizations
Companies covered
- B BIOCYTOGEN
- Charles River Laboratories
- Cyagen Biosciences
- Gempharmatech
- genOway
- ingenious targeting laboratory
- Ozgene Pty Ltd.
- Taconic Biosciences, Inc.
- PolyGene AG
- THE JACKSON LABORATORY
- Yale School of Medicine
- University of North Carolina
- University of Nebraska Medical Center
- Monash University
- UMass Chan Medical School
- University of Bonn
- Columbia University
- The University of Arizona
- The Weizmann Institute of Science
- The Hebrew University of Jerusalem
- The Technion – Israel Institute of Technology
- Hadassah BrainLabs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Mice Model Genetic Engineering Market by Type
- 1.2.1 Global Mice Model Genetic Engineering Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 CRISPR Knockout
- 1.2.3 CRISPR Knockin
- 1.2.4 Random Insertions
- 1.2.5 ES Cell Modification (homologous recombination)
- 1.2.6 Others
- 1.3 Mice Model Genetic Engineering Market by Application
- 1.3.1 Global Mice Model Genetic Engineering Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Biotechnology Companies
- 1.3.4 Academic & Research Facilities
- 1.3.5 Contract Research & Manufacturing Organizations
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Mice Model Genetic Engineering Market Dynamics
- 2.1 Mice Model Genetic Engineering Industry Trends
- 2.2 Mice Model Genetic Engineering Industry Drivers
- 2.3 Mice Model Genetic Engineering Industry Opportunities and Challenges
- 2.4 Mice Model Genetic Engineering Industry Restraints
3 Global Growth Perspective
- 3.1 Global Mice Model Genetic Engineering Market Perspective (2021-2032)
- 3.2 Global Mice Model Genetic Engineering Growth Trends by Region
- 3.2.1 Global Mice Model Genetic Engineering Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Mice Model Genetic Engineering Market Size by Region (2021-2026)
- 3.2.3 Global Mice Model Genetic Engineering Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Mice Model Genetic Engineering Revenue by Players
- 4.1.1 Global Mice Model Genetic Engineering Revenue by Players (2021-2026)
- 4.1.2 Global Mice Model Genetic Engineering Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Mice Model Genetic Engineering Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Mice Model Genetic Engineering Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Mice Model Genetic Engineering Key Players Headquarters & Area Served
- 4.4 Global Mice Model Genetic Engineering Players, Product Type & Application
- 4.5 Global Mice Model Genetic Engineering Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Mice Model Genetic Engineering Market CR5 and HHI
- 4.6.3 2025 Mice Model Genetic Engineering Tier 1, Tier 2, and Tier 3
5 Mice Model Genetic Engineering Market Size by Type
- 5.1 Global Mice Model Genetic Engineering Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Mice Model Genetic Engineering Revenue by Type (2021-2032)
- 5.3 Global Mice Model Genetic Engineering Revenue Market Share by Type (2021-2032)
6 Mice Model Genetic Engineering Market Size by Application
- 6.1 Global Mice Model Genetic Engineering Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Mice Model Genetic Engineering Revenue by Application (2021-2032)
- 6.3 Global Mice Model Genetic Engineering Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 B BIOCYTOGEN
- 7.1.1 B BIOCYTOGEN Company Information
- 7.1.2 B BIOCYTOGEN Business Overview
- 7.1.3 B BIOCYTOGEN Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.1.4 B BIOCYTOGEN Mice Model Genetic Engineering Product Portfolio
- 7.1.5 B BIOCYTOGEN Recent Developments
- 7.2 Charles River Laboratories
- 7.2.1 Charles River Laboratories Company Information
- 7.2.2 Charles River Laboratories Business Overview
- 7.2.3 Charles River Laboratories Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.2.4 Charles River Laboratories Mice Model Genetic Engineering Product Portfolio
- 7.2.5 Charles River Laboratories Recent Developments
- 7.3 Cyagen Biosciences
- 7.3.1 Cyagen Biosciences Company Information
- 7.3.2 Cyagen Biosciences Business Overview
- 7.3.3 Cyagen Biosciences Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.3.4 Cyagen Biosciences Mice Model Genetic Engineering Product Portfolio
- 7.3.5 Cyagen Biosciences Recent Developments
- 7.4 Gempharmatech
- 7.4.1 Gempharmatech Company Information
- 7.4.2 Gempharmatech Business Overview
- 7.4.3 Gempharmatech Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.4.4 Gempharmatech Mice Model Genetic Engineering Product Portfolio
- 7.4.5 Gempharmatech Recent Developments
- 7.5 genOway
- 7.5.1 genOway Company Information
- 7.5.2 genOway Business Overview
- 7.5.3 genOway Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.5.4 genOway Mice Model Genetic Engineering Product Portfolio
- 7.5.5 genOway Recent Developments
- 7.6 ingenious targeting laboratory
- 7.6.1 ingenious targeting laboratory Company Information
- 7.6.2 ingenious targeting laboratory Business Overview
- 7.6.3 ingenious targeting laboratory Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.6.4 ingenious targeting laboratory Mice Model Genetic Engineering Product Portfolio
- 7.6.5 ingenious targeting laboratory Recent Developments
- 7.7 Ozgene Pty Ltd.
- 7.7.1 Ozgene Pty Ltd. Company Information
- 7.7.2 Ozgene Pty Ltd. Business Overview
- 7.7.3 Ozgene Pty Ltd. Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.7.4 Ozgene Pty Ltd. Mice Model Genetic Engineering Product Portfolio
- 7.7.5 Ozgene Pty Ltd. Recent Developments
- 7.8 Taconic Biosciences, Inc.
- 7.8.1 Taconic Biosciences, Inc. Company Information
- 7.8.2 Taconic Biosciences, Inc. Business Overview
- 7.8.3 Taconic Biosciences, Inc. Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.8.4 Taconic Biosciences, Inc. Mice Model Genetic Engineering Product Portfolio
- 7.8.5 Taconic Biosciences, Inc. Recent Developments
- 7.9 PolyGene AG
- 7.9.1 PolyGene AG Company Information
- 7.9.2 PolyGene AG Business Overview
- 7.9.3 PolyGene AG Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.9.4 PolyGene AG Mice Model Genetic Engineering Product Portfolio
- 7.9.5 PolyGene AG Recent Developments
- 7.10 THE JACKSON LABORATORY
- 7.10.1 THE JACKSON LABORATORY Company Information
- 7.10.2 THE JACKSON LABORATORY Business Overview
- 7.10.3 THE JACKSON LABORATORY Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.10.4 THE JACKSON LABORATORY Mice Model Genetic Engineering Product Portfolio
- 7.10.5 THE JACKSON LABORATORY Recent Developments
- 7.11 Yale School of Medicine
- 7.11.1 Yale School of Medicine Company Information
- 7.11.2 Yale School of Medicine Business Overview
- 7.11.3 Yale School of Medicine Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.11.4 Yale School of Medicine Mice Model Genetic Engineering Product Portfolio
- 7.11.5 Yale School of Medicine Recent Developments
- 7.12 University of North Carolina
- 7.12.1 University of North Carolina Company Information
- 7.12.2 University of North Carolina Business Overview
- 7.12.3 University of North Carolina Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.12.4 University of North Carolina Mice Model Genetic Engineering Product Portfolio
- 7.12.5 University of North Carolina Recent Developments
- 7.13 University of Nebraska Medical Center
- 7.13.1 University of Nebraska Medical Center Company Information
- 7.13.2 University of Nebraska Medical Center Business Overview
- 7.13.3 University of Nebraska Medical Center Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.13.4 University of Nebraska Medical Center Mice Model Genetic Engineering Product Portfolio
- 7.13.5 University of Nebraska Medical Center Recent Developments
- 7.14 Monash University
- 7.14.1 Monash University Company Information
- 7.14.2 Monash University Business Overview
- 7.14.3 Monash University Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.14.4 Monash University Mice Model Genetic Engineering Product Portfolio
- 7.14.5 Monash University Recent Developments
- 7.15 UMass Chan Medical School
- 7.15.1 UMass Chan Medical School Company Information
- 7.15.2 UMass Chan Medical School Business Overview
- 7.15.3 UMass Chan Medical School Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.15.4 UMass Chan Medical School Mice Model Genetic Engineering Product Portfolio
- 7.15.5 UMass Chan Medical School Recent Developments
- 7.16 University of Bonn
- 7.16.1 University of Bonn Company Information
- 7.16.2 University of Bonn Business Overview
- 7.16.3 University of Bonn Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.16.4 University of Bonn Mice Model Genetic Engineering Product Portfolio
- 7.16.5 University of Bonn Recent Developments
- 7.17 Columbia University
- 7.17.1 Columbia University Company Information
- 7.17.2 Columbia University Business Overview
- 7.17.3 Columbia University Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.17.4 Columbia University Mice Model Genetic Engineering Product Portfolio
- 7.17.5 Columbia University Recent Developments
- 7.18 The University of Arizona
- 7.18.1 The University of Arizona Company Information
- 7.18.2 The University of Arizona Business Overview
- 7.18.3 The University of Arizona Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.18.4 The University of Arizona Mice Model Genetic Engineering Product Portfolio
- 7.18.5 The University of Arizona Recent Developments
- 7.19 The Weizmann Institute of Science
- 7.19.1 The Weizmann Institute of Science Company Information
- 7.19.2 The Weizmann Institute of Science Business Overview
- 7.19.3 The Weizmann Institute of Science Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.19.4 The Weizmann Institute of Science Mice Model Genetic Engineering Product Portfolio
- 7.19.5 The Weizmann Institute of Science Recent Developments
- 7.20 The Hebrew University of Jerusalem
- 7.20.1 The Hebrew University of Jerusalem Company Information
- 7.20.2 The Hebrew University of Jerusalem Business Overview
- 7.20.3 The Hebrew University of Jerusalem Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.20.4 The Hebrew University of Jerusalem Mice Model Genetic Engineering Product Portfolio
- 7.20.5 The Hebrew University of Jerusalem Recent Developments
- 7.21 The Technion – Israel Institute of Technology
- 7.21.1 The Technion – Israel Institute of Technology Company Information
- 7.21.2 The Technion – Israel Institute of Technology Business Overview
- 7.21.3 The Technion – Israel Institute of Technology Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.21.4 The Technion – Israel Institute of Technology Mice Model Genetic Engineering Product Portfolio
- 7.21.5 The Technion – Israel Institute of Technology Recent Developments
- 7.22 Hadassah BrainLabs
- 7.22.1 Hadassah BrainLabs Company Information
- 7.22.2 Hadassah BrainLabs Business Overview
- 7.22.3 Hadassah BrainLabs Mice Model Genetic Engineering Revenue and Gross Margin (2021-2026)
- 7.22.4 Hadassah BrainLabs Mice Model Genetic Engineering Product Portfolio
- 7.22.5 Hadassah BrainLabs Recent Developments
8 North America
- 8.1 North America Mice Model Genetic Engineering Revenue (2021-2032)
- 8.2 North America Mice Model Genetic Engineering Revenue by Type (2021-2032)
- 8.2.1 North America Mice Model Genetic Engineering Revenue by Type (2021-2026)
- 8.2.2 North America Mice Model Genetic Engineering Revenue by Type (2027-2032)
- 8.3 North America Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
- 8.4 North America Mice Model Genetic Engineering Revenue by Application (2021-2032)
- 8.4.1 North America Mice Model Genetic Engineering Revenue by Application (2021-2026)
- 8.4.2 North America Mice Model Genetic Engineering Revenue by Application (2027-2032)
- 8.5 North America Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
- 8.6 North America Mice Model Genetic Engineering Revenue by Country
- 8.6.1 North America Mice Model Genetic Engineering Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Mice Model Genetic Engineering Revenue by Country (2021-2026)
- 8.6.3 North America Mice Model Genetic Engineering Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Mice Model Genetic Engineering Revenue (2021-2032)
- 9.2 Europe Mice Model Genetic Engineering Revenue by Type (2021-2032)
- 9.2.1 Europe Mice Model Genetic Engineering Revenue by Type (2021-2026)
- 9.2.2 Europe Mice Model Genetic Engineering Revenue by Type (2027-2032)
- 9.3 Europe Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
- 9.4 Europe Mice Model Genetic Engineering Revenue by Application (2021-2032)
- 9.4.1 Europe Mice Model Genetic Engineering Revenue by Application (2021-2026)
- 9.4.2 Europe Mice Model Genetic Engineering Revenue by Application (2027-2032)
- 9.5 Europe Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
- 9.6 Europe Mice Model Genetic Engineering Revenue by Country
- 9.6.1 Europe Mice Model Genetic Engineering Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Mice Model Genetic Engineering Revenue by Country (2021-2026)
- 9.6.3 Europe Mice Model Genetic Engineering Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Mice Model Genetic Engineering Revenue (2021-2032)
- 10.2 China Mice Model Genetic Engineering Revenue by Type (2021-2032)
- 10.2.1 China Mice Model Genetic Engineering Revenue by Type (2021-2026)
- 10.2.2 China Mice Model Genetic Engineering Revenue by Type (2027-2032)
- 10.3 China Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
- 10.4 China Mice Model Genetic Engineering Revenue by Application (2021-2032)
- 10.4.1 China Mice Model Genetic Engineering Revenue by Application (2021-2026)
- 10.4.2 China Mice Model Genetic Engineering Revenue by Application (2027-2032)
- 10.5 China Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Mice Model Genetic Engineering Revenue (2021-2032)
- 11.2 Asia Mice Model Genetic Engineering Revenue by Type (2021-2032)
- 11.2.1 Asia Mice Model Genetic Engineering Revenue by Type (2021-2026)
- 11.2.2 Asia Mice Model Genetic Engineering Revenue by Type (2027-2032)
- 11.3 Asia Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
- 11.4 Asia Mice Model Genetic Engineering Revenue by Application (2021-2032)
- 11.4.1 Asia Mice Model Genetic Engineering Revenue by Application (2021-2026)
- 11.4.2 Asia Mice Model Genetic Engineering Revenue by Application (2027-2032)
- 11.5 Asia Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
- 11.6 Asia Mice Model Genetic Engineering Revenue by Country
- 11.6.1 Asia Mice Model Genetic Engineering Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Mice Model Genetic Engineering Revenue by Country (2021-2026)
- 11.6.3 Asia Mice Model Genetic Engineering Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Mice Model Genetic Engineering Revenue (2021-2032)
- 12.2 SAMEA Mice Model Genetic Engineering Revenue by Type (2021-2032)
- 12.2.1 SAMEA Mice Model Genetic Engineering Revenue by Type (2021-2026)
- 12.2.2 SAMEA Mice Model Genetic Engineering Revenue by Type (2027-2032)
- 12.3 SAMEA Mice Model Genetic Engineering Revenue Share by Type (2021-2032)
- 12.4 SAMEA Mice Model Genetic Engineering Revenue by Application (2021-2032)
- 12.4.1 SAMEA Mice Model Genetic Engineering Revenue by Application (2021-2026)
- 12.4.2 SAMEA Mice Model Genetic Engineering Revenue by Application (2027-2032)
- 12.5 SAMEA Mice Model Genetic Engineering Revenue Share by Application (2021-2032)
- 12.6 SAMEA Mice Model Genetic Engineering Revenue by Country
- 12.6.1 SAMEA Mice Model Genetic Engineering Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Mice Model Genetic Engineering Revenue by Country (2021-2026)
- 12.6.3 SAMEA Mice Model Genetic Engineering Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst